A qualitative study of increasing β-blocker use after myocardial infarction -: Why do some hospitals succeed?

被引:226
|
作者
Bradley, EH
Holmboe, ES
Mattera, JA
Roumanis, SA
Radford, MJ
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[3] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
来源
关键词
D O I
10.1001/jama.285.20.2604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Based on evidence that beta -blockers can reduce mortality in patients with acute myocardial infarction (AMI), many hospitals have initiated performance improvement efforts to increase prescription of beta -blockers at discharge, Determination of the factors associated with such improvements may provide guidance to hospitals that have been less successful in increasing beta -blocker use, Objectives To identify factors that may influence the success of improvement efforts to increase beta -blocker use after AMI and to develop a taxonomy for classifying such efforts. Design, Setting, and Participants Qualitative study in which data were gathered from in-depth interviews conducted in March-June 2000 with 45 key physician, nursing, quality management, and administrative participants at 8 US hospitals chosen to represent a range of hospital sizes, geographic regions, and changes in beta -blocker use rates between October 1996 and September 1999. Main Outcome Measures initiatives, strategies, and approaches to improve care for patients with AMI. Results The interviews revealed 6 broad factors that characterized hospital-based improvement efforts: goals of the efforts, administrative support, support among clinicians, design and implementation of improvement initiatives, use of data, and modifying variables. Hospitals with greater improvements in beta -blocker use over time demonstrated 4 characteristics not found in hospitals with less or no improvement: shared goals for improvement, substantial administrative support, strong physician leadership advocating beta -blocker use, and use of credible data feedback, Conclusions This study provides a context for understanding efforts to improve care in the hospital setting by describing a taxonomy for classifying and evaluating such efforts. In addition, the study suggests possible elements of successful efforts to increase beta -blocker use for patients with AMI.
引用
收藏
页码:2604 / 2611
页数:8
相关论文
共 50 条
  • [1] Factors associated with beta blocker use after myocardial infarction
    Tenaglia, AN
    Horswell, RL
    Scheffler, S
    Livaudais, GF
    CIRCULATION, 1997, 96 (08) : 3947 - 3947
  • [2] Optimizing beta-blocker use after myocardial infarction
    Howard, PA
    Ellerbeck, EF
    AMERICAN FAMILY PHYSICIAN, 2000, 62 (08) : 1853 - 1860
  • [3] WHY DO PATIENTS DIE AFTER MYOCARDIAL-INFARCTION
    JULIAN, DG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S80 - S82
  • [4] β-Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
    Andell, Pontus
    Erlinge, David
    Smith, J. Gustav
    Sundstrom, Johan
    Lindahl, Bertil
    James, Stefan
    Koul, Sasha
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (04):
  • [5] Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario
    Rochon, PA
    Anderson, GM
    Tu, JV
    Clark, JP
    Gurwitz, JH
    Szalai, JP
    Lau, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1999, 161 (11) : 1403 - 1408
  • [6] Beta-Blocker Use in US Nursing Home Residents After Myocardial Infarction: A National Study
    Zullo, Andrew R.
    Lee, Yoojin
    Daiello, Lori A.
    Mor, Vincent
    Boscardin, W. John
    Dore, David D.
    Miao, Yinghui
    Fung, Kathy Z.
    Komaiko, Kiya D. R.
    Steinman, Michael A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 (04) : 754 - 762
  • [7] Can β-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction?
    Faxon, David P.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2004, 1 (01): : 14 - 15
  • [8] Can β-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction?
    David P Faxon
    Nature Clinical Practice Cardiovascular Medicine, 2004, 1 : 14 - 15
  • [9] Beta Blocker Use Among United States Nursing Home Residents After Myocardial Infarction: A National Study
    Zullo, A. R.
    Lee, Y.
    Mor, V.
    Daiello, L.
    Komaiko, K.
    Boscardin, W. J.
    Steinman, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S7 - S7
  • [10] Type of β-blocker use among patients with versus without diabetes after myocardial infarction
    Arnold, Suzanne V.
    Spertus, John A.
    Lipska, Kasia J.
    Lanfear, David E.
    Tang, Fengming
    Grodzinsky, Anna
    McGuire, Darren K.
    Gore, M. Odette
    Goyal, Abhinav
    Maddox, Thomas M.
    Kosiborod, Mikhail
    AMERICAN HEART JOURNAL, 2014, 168 (03) : 273 - U60